in comparison , appg-probenecid eradicated 125 ( 98.4 % ) of 127 urethral or endocervical gonococcal infections , 17 ( 94 % ) of 18 rectal infections , and 4 ( 100 % ) of 4 pharyngeal infections .
C0030830
appg
C0018081
gonococcal infections